Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/127981
Title: Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer
Author: Ramalho-Carvalho, João
Graça, Inês
Gómez, Antonio
Oliveira, Jorge
Henrique, Rui
Esteller, Manel
Jerónimo, Carmen
Keywords: Càncer de pròstata
Fenotip
Micro RNAs
Metilació
Cèl·lules canceroses
Envelliment
Prostate cancer
Phenotype
MicroRNAs
Methylation
Cancer cells
Aging
Issue Date: 6-Feb-2017
Publisher: BioMed Central
Abstract: Background: numerous DNA-damaging cellular stresses, including oncogene activation and DNA-damage response (DDR), may lead to cellular senescence. Previous observations linked microRNA deregulation with altered senescent patterns, prompting us to investigate whether epigenetic repression of microRNAs expression might disrupt senescence in prostate cancer (PCa) cells. Methods: differential methylation mapping in prostate tissues was carried using Infinium HumanMethylation450 BeadChip. After validation of methylation and expression analyses in a larger series of prostate tissues, the functional role of the cluster miR-130b~301b was explored using in vitro studies testing cell viability, apoptosis, invasion and DNA damage in prostate cancer cell lines. Western blot and RT-qPCR were performed to support those observations. Results: we found that the miR-130b~301b cluster directs epigenetic activation of cell cycle inhibitors required for DDR activation, thus stimulating the senescence-associated secretory phenotype (SASP). Furthermore, overexpression of miR-130b~301b cluster markedly reduced the malignant phenotype of PCa cells. Conclusions: altogether, these data demonstrate that miR-130b~301b cluster overexpression might effectively induce PCa cell growth arrest through epigenetic regulation of proliferation-blocking genes and activation of cellular senescence.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s13045-017-0415-1
It is part of: Journal of Hematology & Oncology, 2017, vol. 10, num. 1, p. 43
URI: http://hdl.handle.net/2445/127981
Related resource: https://doi.org/10.1186/s13045-017-0415-1
ISSN: 1756-8722
Appears in Collections:Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
670729.pdf1.62 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons